Bitcoin Prices Slip on Thursday May 28 2026 Morning Losses Extend Decline SpaceX IPO Opens to Retail Investors via Major Brokerage Platforms Tesla Surpasses Profit Expectations Despite Revenue Miss as Auto Margins Improve Alberta Separation Referendum Carney Highlights Provinces Essential Role in Canadian Economy Rajnath Singh Highlights Strategic Autonomy and Rising Private Sector Role in Indias Defence Sector Why Market Perception Not Performance Drives Stock Profits Lessons from Robert Wilson Costamare Q1 2026 Earnings EPS Misses Estimates Shares Decline 42 NTCT Q1 2026 Earnings EPS Surpasses Estimates as Company Delivers Strong Profitability EXP Q1 2026 Earnings EPS Surges Past Estimates Strong Operational Performance Westwater Resources Inc WWR Q1 2026 Earnings Narrow Loss Beats Estimates as Stock Surges 25 FirstService Corporation FSV Q1 2026 Earnings Earnings Beat Drives Optimism Yet Shares Edge Lower Danaos Corporation Q1 2026 Earnings Modest EPS Miss Amid Stable Charter Operations Tailwind 20 Acquisition Corp TDWD Holds Steady at 1000 as SPAC Investors Await Business Combination Catalyst Locafy Warrant LCFYW Holds Steady at 371 Sideways Action Nears Key Support Aspire Biopharma Holdings Warrants ASBPW Languish at Penny Level as Support and Resistance Converge Shake Shack SHAK Holds Near Support as Trading Volume Normalizes Sturm Ruger RGR Holds Steady at 3961 Consolidation in a Defensive Sector CWAN Q1 2026 Earnings Slight EPS Miss Amid Steady Operations Home BancShares Inc HOMB Q1 2026 Earnings Slight EPS Miss Masked by Strong Underlying Trends VCTR Q1 2026 Earnings EPS Beats Estimates Amid Strong Operating Performance Perspective Therapeutics Inc CATX Q1 2026 Earnings EPS Beat by 17 as PreRevenue Biotech Advances Radiopharmaceutical Pipeline IBM Q1 2026 Earnings EPS Surpasses Estimates as Company Continues Strategic Transformation CVU Q1 2021 Earnings EPS Surges Past Estimates Stock Gains Indian Billionaires Accelerate Global Acquisition Spree Amid Slowing Domestic Growth Dermata Therapeutics DRMA Q1 2026 Earnings Narrower Loss Surprises as PreRevenue Biotech Continues Pipeline Progress Insmed Surges 248 as Biotech Stock Tests Key Resistance